Chester County News and Community Website
WAYNE, PA — Aclaris Therapeutics, Inc. (NASDAQ: ACRS) this week announced preliminary topline results from a 12-week, Phase 2a, multicenter, randomized, placebo-controlled clinical study to investigate the efficacy, safety, tolerability, …
Zunsemetinib: A Potential Game Changer for HS Patients Read More
MALVERN, PA — Ocugen, Inc. (NASDAQ: OCGN) this week announced that it has submitted an Investigational New Drug application (IND) with the U.S. Food and Drug Administration (FDA) to initiate …
Ocugen’s Milestone: Submitting OCU200 for Phase 1 Clinical Trial Read More
CHESTERBROOK, PA — Trevena, Inc. (Nasdaq: TRVN) announced the recent publication of OLINVYK data in the peer-reviewed journal Anesthesiology. The paper, entitled “Respiratory Effects of Biased Ligand Oliceridine in Older …
Trevena Announces Publication of OLINVYK Respiratory Physiology Study Read More
BERWYN, PA — Annovis Bio, Inc. (NYSE: ANVS) announced recent approval for additional European clinical trial sites for the ongoing Phase 3 study of buntanetap for the treatment of Parkinson’s disease (“PD”).
Annovis Bio Announces Approval for European Union Clinical Trial Sites for the Phase 3 Study of Buntanetap Read More
EXTON, PA — Aceragen, Inc. (Nasdaq: ACGN) announced the recent recommendation of its independent Data Monitoring Committee (DMC) in regard to the on-going TERRA Phase 2 study of ACG-701 in …
TERRA Phase 2 Study of ACG-701 Continues Without Modification Read More
DEVON, PA — Zynerba Pharmaceuticals, Inc. (Nasdaq: ZYNE) announced the recent publication of a paper entitled, “Role of the Endocannabinoid System in Fragile X Syndrome: Potential Mechanisms for Benefit From …
Cannabidiol May Be a Potential Treatment for Fragile X Syndrome Read More
EXTON, PA — Castle Creek Biosciences announced the recent publication of a preclinical study that found that its experimental in vivo gene therapy treatment resolved biochemical and hepatic histological markers …
Castle Creek Biosciences Announces Publication of Preclinical Study for Potential In Vivo Gene Therapy in Nature Communications Read More
MALVERN, PA — LifeScan announced recruitment for a new study that will evaluate the clinical and economic value of using the digital health subscriptions offered through OneTouch® Solutions for people with type 2 …
New Study Will Examine Benefits for People with Type 2 Diabetes When Personalized Wellness Technologies Are Paired With Smart Blood Glucose Ecosystem Read More